KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $6.6 billion.

  • AbbVie's Free Cash Flow rose 2779.92% to $6.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $19.7 billion, marking a year-over-year increase of 2599.37%. This contributed to the annual value of $17.8 billion for FY2024, which is 1917.32% down from last year.
  • Latest data reveals that AbbVie reported Free Cash Flow of $6.6 billion as of Q3 2025, which was up 2779.92% from $4.9 billion recorded in Q2 2025.
  • Over the past 5 years, AbbVie's Free Cash Flow peaked at $7.7 billion during Q3 2021, and registered a low of $1.4 billion during Q1 2025.
  • Over the past 5 years, AbbVie's median Free Cash Flow value was $4.9 billion (recorded in 2025), while the average stood at $5.2 billion.
  • Per our database at Business Quant, AbbVie's Free Cash Flow plummeted by 6694.35% in 2024 and then soared by 14059.11% in 2025.
  • Quarter analysis of 5 years shows AbbVie's Free Cash Flow stood at $4.9 billion in 2021, then skyrocketed by 47.61% to $7.2 billion in 2022, then tumbled by 36.96% to $4.5 billion in 2023, then skyrocketed by 48.57% to $6.8 billion in 2024, then decreased by 1.69% to $6.6 billion in 2025.
  • Its Free Cash Flow was $6.6 billion in Q3 2025, compared to $4.9 billion in Q2 2025 and $1.4 billion in Q1 2025.